Patents Assigned to UAB “Innovita Research”
  • Xenogenic normal tissue-derived vaccines for breaking the immune tolerance to tumor-associated, antigens
    Patent number: 10695408
    Abstract: Disclosed is an antitumor vaccine including testicular and fetal tissue-derived components. Cell preparations are prepared from normal tissues harvested directly from animals. Such vaccines may be used in the treatment and prevention of different cancers. For example, a vaccine consisting of glutaraldehyde-treated cells prepared from sheep testis and fetal lung has been found to be effective in inducing antitumor cell-mediated responses, as well as in prolonging the survival of mice with lung cancer.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: June 30, 2020
    Assignee: UAB “Innovita Research”
    Inventors: Victor I. Seledtsov, Galina V. Seledtsova, Adas Darinskas